Fieldpoint Private Securities’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Fieldpoint Private Securities's VRTX Position: Q2 2022 in Review
Fieldpoint Private Securities reduced its Vertex Pharmaceuticals (VRTX) stake by 8.2% in Q2 2022, selling an estimated $6.69K and leaving 280 shares worth $79K. The position accounts for 0.02% of the portfolio, ranked #404.
Fieldpoint Private Securities first reported a position in VRTX in Q4 2020 and has held it in 7 quarters since. The position peaked at $80K in Q1 2022. 1,107 funds tracked by Wall St. Rank hold VRTX as of Q2 2022.
- Fieldpoint Private Securities held 280 shares of Vertex Pharmaceuticals worth $79K as of Q2 2022.
- Fieldpoint Private Securities sold 25 Vertex Pharmaceuticals shares in Q2 2022, an estimated $6.69K.
- Vertex Pharmaceuticals made up 0.02% of Fieldpoint Private Securities's portfolio in Q2 2022, its #404 holding.
- Fieldpoint Private Securities first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 7 quarters since.
- Fieldpoint Private Securities's Vertex Pharmaceuticals position peaked at $80K in Q1 2022.
- 1,107 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2022.
Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.